Se encuentra usted aquí

08
Mar
Lun, 08/03/2021 - 12:27

Predicting how brain cancer responds to immunotherapy non-invasively

Predicting how brain cancer responds to immunotherapy non-invasively

A new study in Nature Communications describes a new method developed by CNAG-CRG and VHIO

04
Mar
Jue, 04/03/2021 - 11:09

Facial development in Down syndrome and green tea extracts

Facial development in Down syndrome and green tea extracts

The intake of green tea extracts potentially reduces facial dysmorphology in children with Down syndrome

01
Mar
Lun, 01/03/2021 - 15:50

CRG signs biodiversity genomic sequencing agreement with Andorra

CRG signs biodiversity genomic sequencing agreement with Andorra

This is the first time the country has been involved in a project of this magnitude

01
Mar
Lun, 01/03/2021 - 11:08

Single cell sequencing opens new avenues for eradicating leukaemia at its source

Single cell sequencing opens new avenues for eradicating leukaemia at its source

A new tool can boost international research efforts to find cancer drugs

26
Feb
Vie, 26/02/2021 - 11:11

Barcelona platform facilitates diagnosis of one thousand rare disease patients

Barcelona platform facilitates diagnosis of one thousand rare disease patients

The researchers have announced the milestone to mark Rare Disease Day 2021, held this Sunday

18
Feb
Jue, 18/02/2021 - 11:33

Researchers chart a three-dimensional genomic map of healthy and cancerous lymphocytes

Researchers chart a three-dimensional genomic map of healthy and cancerous lymphocytes

The map reveals new points of vulnerability to target therapeutically in tumour cells 

10
Feb
Mié, 10/02/2021 - 17:01

Earliest signs of an immune response found in developing embryos

Earliest signs of an immune response found in developing embryos

Findings may lead to new clinical efforts in treating infertility or early miscarriages

09
Feb
Mar, 09/02/2021 - 09:42

People with Down syndrome are genetically susceptible to COVID-19

People with Down syndrome are genetically susceptible to COVID-19

Their findings boost existing calls for priority vaccination of the medically vulnerable group

  • Group page
  • Research lines
  • Publications
Programme
Senior Visiting Scientist
Pedro Julio Collado Vides

Staff Scientist
Pedro Julio Collado Vides
1989 Ph.D. in biomedical research, National Autonomous University of Mexico (UNAM), Mexico
1989-1992 Posdoctoral fellow, Department of Biology, Laboratory of Dr. Boris Magasanik, Massachusetts Institute of Technology, Cambridge, USA
1992-1997
17
Dec
Jue, 17/12/2020 - 09:30

Resuscitating eyes to speed up clinical research for vision impairment

Resuscitating eyes to speed up clinical research for vision impairment

The new method will help researchers assess the efficacy, efficiency, and safety of new regenerative therapies and drug testing for eyesight loss

Páginas